Brief: Allena Pharmaceuticals Reports Q2 Loss Per Share $0.42

Allena Pharmaceuticals

07/08/2018 13:04

Aug 7 (Reuters) - Allena Pharmaceuticals Inc  ALNA.O :
    * ALLENA PHARMACEUTICALS REPORTS SECOND QUARTER 2018
FINANCIAL
RESULTS AND PROVIDES BUSINESS UPDATE
    * Q2 LOSS PER SHARE $0.42
    * Q2 EARNINGS PER SHARE VIEW $-0.40 -- THOMSON REUTERS
I/B/E/S
    * PLAN TO INITIATE URIROX-2™ IN 2H18
    * REITERATES GUIDANCE
    * ALLENA PHARMACEUTICALS - EXPECT CASH, CASH EQUIVALENTS TO
BE
SUFFICIENT TO FUND OPERATING. EXPENSES , CAPITAL REQUIREMENTS
INTO 2020

Source text for Eikon:  ID:nGNX3q5N4F 
Further company coverage:  ALNA.O 

 (Reuters.Briefs@thomsonreuters.com)